356 related articles for article (PubMed ID: 15760433)
1. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
[TBL] [Abstract][Full Text] [Related]
2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
3. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
4. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
[TBL] [Abstract][Full Text] [Related]
5. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
Walsh F; Willcock J; Amyes S
J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
[TBL] [Abstract][Full Text] [Related]
6. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia.
Reinert RR; Filimonova OY; Al-Lahham A; Grudinina SA; Ilina EN; Weigel LM; Sidorenko SV
Antimicrob Agents Chemother; 2008 Jun; 52(6):2260-2. PubMed ID: 18378707
[TBL] [Abstract][Full Text] [Related]
8. In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study.
Neeleman C; De Valk JA; Klaassen CH; Meijers S; Mouton JW
Clin Microbiol Infect; 2005 Apr; 11(4):312-8. PubMed ID: 15760429
[TBL] [Abstract][Full Text] [Related]
9. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
Hoban DJ; Wierzbowski AK; Nichol K; Zhanel GG
Antimicrob Agents Chemother; 2001 Jul; 45(7):2147-50. PubMed ID: 11408241
[TBL] [Abstract][Full Text] [Related]
10. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France.
Marchandin H; Jean-Pierre H; Jumas-Bilak E; Isson L; Drouillard B; Darbas H; Carrière C
Pathol Biol (Paris); 2001 Sep; 49(7):522-7. PubMed ID: 11642013
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.
Rantala M; Huikko S; Huovinen P; Jalava J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4180-4. PubMed ID: 16189096
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
14. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
15. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.
Davies TA; Bush K; Sahm D; Evangelista A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393
[TBL] [Abstract][Full Text] [Related]
16. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
Wierzbowski AK; Boyd D; Mulvey M; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
Dobay O; Rozgonyi F; Amyes SG
Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.
Reinert RR; van der Linden M; Al-Lahham A
Antimicrob Agents Chemother; 2005 Aug; 49(8):3520-2. PubMed ID: 16048973
[TBL] [Abstract][Full Text] [Related]
19. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
Gulay Z; Ozbek OA; Bicmen M; Gur D
Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
